Observational studyEpilepsia2026

Add-on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss-of-function γ-aminobutyric acid type A receptor variants.

Cathrine E Gjerulfsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.